Abstract:BACKGROUND: International travel continues to increase, particularly to Asia and Africa. Clinicians are increasingly likely to be consulted for advice before travel or by ill returned travelers.OBJECTIVE: To describe typical diseases in returned travelers according to region, travel reason, and patient demographic characteristics; describe the pattern of low-frequency travel-associated diseases; and refine key messages for care before and after travel.DESIGN: Descriptive, using GeoSentinel records.SETTING: 53 tropical or travel disease units in 24 countries.PATIENTS: 42 173 ill returned travelers seen between 2007 and 2011.MEASUREMENTS: Frequencies of demographic characteristics, regions visited, and illnesses reported.RESULTS: Asia (32.6%) and sub-Saharan Africa (26.7%) were the most common regions where illnesses were acquired. Three quarters of travel-related illness was due to gastrointestinal (34.0%), febrile (23.3%), and dermatologic (19.5%) diseases. Only 40.5% of all ill travelers reported pretravel medical visits. The relative frequency of many diseases varied with both travel destination and reason for travel, with travelers visiting friends and relatives in their country of origin having both a disproportionately high burden of serious febrile illness and very low rates of advice before travel (18.3%). Life-threatening diseases, such as Plasmodium falciparum malaria, melioidosis, and African trypanosomiasis, were reported.LIMITATIONS: Sentinel surveillance data collected by specialist clinics do not reflect healthy returning travelers or those with mild or self-limited illness. Data cannot be used to infer quantitative risk for illness.CONCLUSION: Many illnesses may have been preventable with appropriate advice, chemoprophylaxis, or vaccination. Clinicians can use these 5-year GeoSentinel data to help tailor more efficient pretravel preparation strategies and evaluate possible differential diagnoses of ill returned travelers according to destination and reason for travel.PRIMARY FUNDING SOURCE: Centers for Disease Control and Prevention.

Reply to Otiti-Sengeri et al. Chorioretinitis among Immigrant and Travellers. Comment on "Mansour et al. Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East. Diagnostics 2023, 13, 3626"

Comment on Dutta Majumder et al.'s 2019 'Ocular Syphilis: An Update'

Comment on Cuesta et al. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis. Diagnostics 2024, 14, 802

GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011

A Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2023, 20, 6309

Clinicopathological study of otomycosis in a tertiary hospital in South-west Nigeria

Reply to Paranhos-Baccalà et al. Comment on "Cuesta et al. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis. Diagnostics 2024, 14, 802"

Authors' Reply to Letter to the Editor- in Response to: Comment on Dheyab AM et al. "Long-Term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis"

Comment on ‘The positive HIV result in a routine systemics screening in a dermatology clinic’

Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study

Reply to Cetkovic et al. Comment on "Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444"

Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis

Chorioretinopathy Post COVID-19: A Systematic Review and Prevalence Assessment, Unveiling Insights into an Emerging Ocular Entity

Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique

Authors reply: comments on the published meta-analysis of antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries

Onchocerciasis among Ethiopian immigrants in Israel

Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya

Reply to "discussion on the Insufficiency of Criteria for Diagnosis of Toxoplasmosis (WS/T 486-2015) and Treatment of Toxoplasma Gondii Infection in Pregnancy"

Reply to Itagaki et al. Comment on "Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416"

[Chronic communicable and non-communicable pathology and skin pathology of the migrant patient]

It's Not Always Infections When It Comes to Resource-Poor Countries: A Fascinating Case Report